Table 1 Patient Characteristics

From: Polyclonal expansion of functional tumor-reactive lymphocytes infiltrating glioblastoma for personalized cell therapy

Number of cases

IDH-wt (n = 138)

IDH-mut (n = 23)

  

Astrocytoma (n = 14)

Oligodendroglioma (n = 6)

Recurrent GB (n = 3)

  

Grade 4 (n = 5)

Grade 3 (n = 8)

Grade 2 (n = 1)

Grade 3 (n = 4)

Grade 2 (n = 2)

Grade 4 (n = 2)

Grade 3 (n = 1)

Age (Mean ± SD)

60.7 ± 10.2

48.8 ± 10.2

42 ± 8.8

64

45.2 ± 22.8

46.5 ± 14.8

46.5 ± 4.9

39

Gender

 Male

100

5

2

1

2

2

2

1

 Female

38

0

6

0

2

0

0

0

MGMT

 UnMet

94

2

3

0

0

0

1

0

 Met

44

3

5

1

4

2

1

1

expanded

81

0

0

1

3

0

2

0

not expanded

57

5

8

0

1

2

0

1

  1. IDH1 = Isocitrate dehydrogenase; MGMT = O-6-methylguanine-DNA methyltransferase; n = number.
  2. The correlation between IDH1 mutation and expansion outcome is present in the corresponding source data.
Back to article page